Ortho Clinical Diagnostics and Thermo Fisher Scientific's BRAHMS announced a strategic relationship aimed at developing the BRAHMS PCT assay for use on Ortho's Vitros immunodiagnostics and integrated systems. The procalcitonin assay, designed to aid in sepsis management along with the use of other laboratory findings and clinical assessment, helps determine which patients are at high risk of septic shock and when antibiotics can be safely discontinued.
Ortho, Thermo Fisher's BRAHMS partner on PCT assay development
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.